Counterfeit Version of Avastin In U.S. Distribution

The FDA announced a warning to healthcare professionals and patients about a counterfeit version of Avastin 400mg/16mL, which may have been purchased and used by some medical practices in the United States.

The counterfeit version is labeled as Avastin, manufactured by Roche and does not contain the medicine's active ingredient, bevacizumab, which my have resulted in patients not receiving needed therapy. 

Avastin is an injectable medicine used to treat various types of cancer, including brain cancer, and is administered to patients in clinics, hospitals, and doctors' offices.

Click here for FDA announcement.

 

Share |
December 4, 2014 02:02 PM
Concert proceeds benefit Accelerate Brain Cancer Cure.
November 24, 2014 04:43 PM
ABC2-funded research in the news and a blog post by Al Musella, of the Musella Foundation, about Novocure's promising Optune trial results.
November 18, 2014 12:33 PM
Accelerate Brain Cancer Cure funded Duke University's early work on the vaccine.

Join us in our fight for a cure!